Balance Sheet Strength: Jupiter Neurosciences (JUNS) improved its liquidity post-IPO, with $3.77M in cash and a current ratio of 2.31 as of Q4 2024. Minimal long-term debt reduces solvency risk, but $3.9M in annual operating cash outflows highlight ongoing cash burn.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
View 5 tickers daily
Create and manage Watchlists
Import portfolios (no personalized insights)
Chat with the general Sagehood AI Agent
Market Radar: Preview access only
Premium Membership
Unlimited AI-generated insights across all sections
Market Overview
Market Radar (AI-driven investment opportunities)
Access to all Sagehood AI agents, including domain-specific experts
Personalized insights and actionable recommendations for smarter investing